Gao, W., Hu, P., Naing, A., McKean, M., Tolcher, A., Siu, L. L., . . . Holland, D. TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: A first-in-human, phase 1, dose-escalation trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationGao, Wei, et al. TIGIT Inhibitor M6223 as Monotherapy or in Combination with Bintrafusp Alfa in Patients with Advanced Solid Tumors: A First-in-human, Phase 1, Dose-escalation Trial. BMJ Publishing Group.
MLA (9th ed.) CitationGao, Wei, et al. TIGIT Inhibitor M6223 as Monotherapy or in Combination with Bintrafusp Alfa in Patients with Advanced Solid Tumors: A First-in-human, Phase 1, Dose-escalation Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.